Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease-Reference-Cited by-同舟云学术

Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease

Published:2014-09 Issue:3 Volume:14 Page:165-174
ISSN:1346-3500
Container-title:Psychogeriatrics
language:en
Short-container-title:Psychogeriatrics

Author:

Arai Heii¹,Ichimiya Yosuke²,Shibata Nobuto¹,Nakajima Takashi³,Sudoh Shinji⁴,Tokuda Takahiko⁵,Sujaku Tetsujo⁶,Yokokawa Shigeyoshi⁶,Hoshii Naoki⁶,Noguchi Hideaki⁶,Bille Anne⁶

Affiliation:

1. Department of Psychiatry; Juntendo University; Graduate School of Medicine; Tokyo Japan

2. Department of Psychiatry; Faculty of Medicine; Juntendo Tokyo Koto Geriatric Medical Center; Tokyo Japan

3. Department of Neurology; Niigata National Hospital; National Hospital Organization; Niigata Japan

4. Department of Neurology; Utano National Hospital; National Hospital Organization; Kyoto Japan

5. Department of Molecular Pathobiology of Brain Diseases (Department of Neurology); Kyoto Prefectural University of Medicine; Kyoto Japan

6. Baxter Limited; Tokyo Japan

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/psyg.12055/fullpdf

Reference24 articles.

1. Alzheimer disease: mechanistic understanding predicts novel therapies;Selkoe;Ann Intern Med,2004

2. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse;Schenk;Nature,1999

3. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease;Morgan;Nature,2000

4. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease;Hock;Neuron,2003

5. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization;Orgogozo;Neurology,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Assay and Anti-Inflammatory Function Evaluation of Therapeutic Potential of Different Intravenous Immunoglobulins for Alzheimer’s Disease;International Journal of Molecular Sciences;2023-03-14

2. Neuroprotective Effects of IVIG against Alzheimer’ s Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice;The Journal Of Prevention of Alzheimer's Disease;2023

3. Efficacy and safety of blood derivatives therapy in Alzheimer’s disease: a systematic review and meta-analysis;Systematic Reviews;2022-11-29

4. Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders;International Journal of Molecular Sciences;2021-02-05

5. Intravenous immunoglobulins for Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s disease: A systematic review with meta-analysis;Expert Review of Neurotherapeutics;2019-05-23